SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 480,178.20 |
Enterprise Value ($M) | 504,994.20 |
Book Value ($M) | 74,023.00 |
Book Value / Share | 28.13 |
Price / Book | 6.49 |
NCAV ($M) | -43,222.00 |
NCAV / Share | -16.43 |
Price / NCAV | -11.11 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.18 |
Return on Assets (ROA) | 0.11 |
Return on Equity (ROE) | 0.30 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.14 |
Current Ratio | 1.39 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 60,424.00 |
Assets | 178,355.00 |
Liabilities | 103,646.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 93,775.00 |
Operating Income | 24,547.00 |
Net Income | 20,878.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 23,410.00 |
Cash from Investing | -8,683.00 |
Cash from Financing | -14,047.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | State Street Corp | 5.51 | 0.67 | |
13G/A | Vanguard Group Inc | 8.92 | 3.00 | |
13G/A | BlackRock Inc. | 7.60 | 6.11 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
1,101,535 | 6,956,442 | 15.83 | |
1,468,991 | 8,195,758 | 17.92 | |
1,764,663 | 8,616,074 | 20.48 | |
656,218 | 5,234,622 | 12.54 | |
(click for more detail) |
|||
(click for list of largest short owners) |
Financial data and stock pages provided by
Fintel.io